UNSPSC 51173231: Magnesium sulfate/potassium sulfate/sodium sulfate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA202. This VA Drug Class (GA202) classifies this compound as belonging to the group HYPEROSMOTIC LAXATIVES.

UNSPSC 51173231 Magnesium sulfate/potassium sulfate/sodium sulfate is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The three most recent opportunities posted under this code—offender drug testing services in Texas, a pharmacy benefit manager RFI in Texas, and a multistate cooperative pharmaceutical procurement in Minnesota—represent clinical and pharmaceutical supply chains rather than bulk chemical sourcing for the salts named in the code. The mismatch suggests that state and local governments are not actively soliciting magnesium sulfate, potassium sulfate, or sodium sulfate as discrete commodities under this code's designation at present.

The single opportunity with direct operational relevance is Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services, posted July 9, 2026 with proposals due July 23, 2026, estimated at $600,000 annually. That procurement centers on immunoassay screening, LC/MS/MS or GC/MS confirmation testing, and lab certification—activities that may consume test reagents but do not constitute procurement of the salts themselves. The Minnesota MMCAP cooperative purchasing RFP (posted January 20, 2026, due March 26, 2026) and the Texas HHS Commission's RFI on direct-to-manufacturer prescriptions (posted April 3, 2026) likewise address pharmaceutical distribution and benefit management, not chemical inputs. No evidence in the recent opportunities block supports active state or local demand for the bulk salts named in the code, and pursuing this code on the basis of current posting activity is not recommended.